首页 | 本学科首页   官方微博 | 高级检索  
检索        

血浆置换联合血液灌流治疗重度药物性肝病12例临床分析
引用本文:明媛英.血浆置换联合血液灌流治疗重度药物性肝病12例临床分析[J].实用肝脏病杂志,2006,9(3):154-155.
作者姓名:明媛英
作者单位:400700,重庆市第九人民医院感染科
摘    要:目的探讨血浆置换和血液灌流在重度药物性肝损害治疗中的作用。方法对我院2003年~2004年收治的12例重度药物性肝功能损害患者的治疗情况进行回顾性分析。结果12例患者(包括4例急性肝功能衰竭)患者经过内科综合治疗联合血浆置换和血液灌流治疗,均痊愈出院。结论血浆置换联合血液灌流是治疗重度药物性肝损害有效的重要手段。

关 键 词:重度药物性肝功能损害  血浆置换  血液灌流
收稿时间:2006-04-10
修稿时间:2006年4月10日

Clinical analysis on the role of plasmapharesis and hemoperfusion in the treatment of severe drug-induced hepatopathy
Ming Yuanying.Clinical analysis on the role of plasmapharesis and hemoperfusion in the treatment of severe drug-induced hepatopathy[J].Journal of Clinical Hepatology,2006,9(3):154-155.
Authors:Ming Yuanying
Abstract:Objective To investigate the role of plasmapharesis and hemoperfusion in the treatment of severe drug-induced hepatopathy.Methods A retrospective clinical study was undertaken on the therapeutic strategies of the 12 patients of severe drug-induced hepatopathy admitted to our department from 2003 to 2004.Results All these patients (including 4 cases of acute hepatic failure) were cured via plasmapharesis and hemoperfusion combined with other comprehensive treatments.Conclusions Plasmapharesis and hemoperfusion are effective and essential therapeutic methods in treating severe drug-induced hepatopathy.
Keywords:] Severe drug-induced hepatopathy Plasmapharesis Hemoperfusion
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号